0000899243-18-005333.txt : 20180223 0000899243-18-005333.hdr.sgml : 20180223 20180223170042 ACCESSION NUMBER: 0000899243-18-005333 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180222 FILED AS OF DATE: 20180223 DATE AS OF CHANGE: 20180223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hatfield Jeffrey S. CENTRAL INDEX KEY: 0001609879 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36510 FILM NUMBER: 18637472 MAIL ADDRESS: STREET 1: 11080 ROSELLE STREET CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ZAFGEN, INC. CENTRAL INDEX KEY: 0001374690 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203857670 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 175 PORTLAND STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02114 BUSINESS PHONE: 617-622-4003 MAIL ADDRESS: STREET 1: 175 PORTLAND STREET STREET 2: 4TH FLOOR CITY: BOSTON STATE: MA ZIP: 02114 FORMER COMPANY: FORMER CONFORMED NAME: ZAFGEN INC DATE OF NAME CHANGE: 20060906 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-22 0 0001374690 ZAFGEN, INC. ZFGN 0001609879 Hatfield Jeffrey S. C/O ZAFGEN, INC. 175 PORTLAND STREET, 4TH FLOOR BOSTON MA 02114 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 7.77 2018-02-22 4 A 0 275000 0.00 A 2028-02-22 Common Stock 275000 275000 D 25% of this option vests on February 22, 2019, and the remainder vests in equal monthly installments thereafter over 36 months. /s/ Laurie Burlingame, Attorney-in-Fact 2018-02-23